Technical Data
22 Sep 2022
EVER Pharma: Product list of speciality injectables
PDF 106 kB
EVER Pharma's products include:
- Atosiban -- 7.5 mg/ml Solution for Injection/Infusion
- Azacitidine -- 25 mg/ml Powder for Suspension for Injection
- Cabazitaxel -- 10 mg/ml - Solution for Infusion
- Cerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for Infusion
- Dacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml - Solution for Injection/Infusion
- Dexmedetomidine -- 100 µg/ml - Concentrate for Solution for Infusion
- Docetaxel -- 20 mg/ml - Concentrate for injection
- Fulvestrant -- 50 mg/ml - Ready to use pre-filled syringe
- Oxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/Infusion
- Paclitaxel-- 6 mg/ml - Concentrate for Injection
- Pemetrexed -- 25 mg/ml - Concentrate for Solution for Infusion
- Terlipressin -- 0.17 mg/ml - Solution for Injection/Infusion
Content provided by our supplier
EVER Pharma
-
AT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Other Content from EVER Pharma (1)
-
News EVER Pharma gains EU Marketing Authorization for Trabectedin
EVER Pharma announces the EU-wide marketing authorization of Trabectedin (in 0.25MG and 1MG vial sizes) for the treatment of advanced soft tissue sarcoma and ovarian cancer
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance